النهار أونلاين
النهار أونلاين
Ready to play
Ready to play
The article covers a meeting with Algerian Minister of Industry and Pharmaceuticals, Dr. Wassem Kouaidri, who presided over the opening of the Pharma 2026 conference. He emphasized the importance of the Algerian-German partnership in localizing innovative medicines in Algeria. He discussed the development of the national pharmaceutical industry, which now covers 82% of the market’s needs, with a focus on advancing research and innovation and producing high-value-added medicines. Additionally, efforts are underway to manufacture raw materials domestically to enhance industrial integration. He pointed out that signing an agreement with Boehringer Ingelheim represents a significant step toward producing innovative drugs for rare diseases and cancers, thereby strengthening Algeria’s position as a regional pharmaceutical hub.
Notice: This Is an AI-Generated Summary
Comments (0)